mTOR Kinase Inhibition Effectively Decreases Progression of a Subset of Neuroendocrine Tumors That Progress on Rapalog Therapy and Delays Cardiac Impairment

Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-17-0058
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Protein Kinase C Inactivation Inhibits Cellular Proliferation and Decreases Survival in Human Neuroendocrine Tumors

Endocrine-Related Cancer
Cancer ResearchEndocrinologyOncologyMetabolismDiabetes
2011English

Corrigendum: Identifying a Missing Lineage Driver in a Subset of Lung Neuroendocrine Tumors

Genes and Development
GeneticsDevelopmental Biology
2018English

Implication of Filamin a in Pulmonary Neuroendocrine Tumors Aggressiveness and Progression

Endocrine Abstracts
2016English

Angiopoietin-2 Promotes Disease Progression of Neuroendocrine Tumors

Clinical Cancer Research
Cancer ResearchOncology
2010English

Macropinocytosis Renders a Subset of Pancreatic Tumor Cells Resistant to mTOR Inhibition

Cell Reports
BiochemistryGeneticsMolecular Biology
2020English

CXCR4/CXCL12/CXCR7 Axis Is Functional in Neuroendocrine Tumors and Signals on mTOR

Oncotarget
Oncology
2016English

Joint Guidance on Peptide Receptor Radionuclide Therapy in Neuroendocrine Tumors

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2013English

Inhibition of Phosphatidylinositol 3-Kinase/Akt Signaling Suppresses Tumor Cell Proliferation and Neuroendocrine Marker Expression in GI Carcinoid Tumors

Annals of Surgical Oncology
OncologySurgery
2009English

Enhanced Sensitivity of PTEN-deficient Tumors to Inhibition of FRAP/mTOR

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2001English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy